Gene · 4680
Papers1,711
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,711
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Phase 1, Open-Label, Dose-Escalation Study of L-DOS47 in Combination With Pemetrexed Plus Carboplatin in Patients With Stage IV Recurrent or Metastatic Nonsquamous NSCLC. | JTO Clin Res Rep | 2022 | 36268537 | PubTator, text mining | PubMed |
| Hyperdiploidy: the longest known, most prevalent, and most enigmatic form of acute lymphoblastic leukemia in children. | Leukemia | 2022 | 36266323 | PubTator, text mining | PubMed |
| [Update thoracic pathology 2022-Report of the Thoracic Pathology Working Group of the German Society of Pathology]. | Pathologie (Heidelb) | 2022 | 36260123 | PubTator, text mining | PubMed |
| Dendritic Cells: The Long and Evolving Road towards Successful Targetability in Cancer. | Cells | 2022 | 36230990 | PubTator, text mining | PubMed |
| Anoikis-Associated Lung Cancer Metastasis: Mechanisms and Therapies. | Cancers (Basel) | 2022 | 36230714 | PubTator, text mining | PubMed |
| Synthesis and biomedical applications of mucin mimic materials. | Adv Drug Deliv Rev | 2022 | 36228896 | PubTator, text mining | PubMed |
| The cuproptosis-related signature predicts prognosis and indicates immune microenvironment in breast cancer. | Front Genet | 2022 | 36226193 | PubTator, text mining | PubMed |
| Spike S1 domain interactome in non-pulmonary systems: A role beyond the receptor recognition. | Front Mol Biosci | 2022 | 36225252 | PubTator, text mining | PubMed |
| Efficacy of bivalent CEACAM6/4-1BBL genetic vaccine combined with anti-PD1 antibody in MC38 tumor model of mice. | Heliyon | 2022 | 36212004 | PubTator, text mining | PubMed |
| A germline SNP in BRMS1 predisposes patients with lung adenocarcinoma to metastasis and can be ameliorated by targeting c-fos. | Sci Transl Med | 2022 | 36197962 | PubTator, text mining | PubMed |
| Treatment-associated remodeling of the pancreatic cancer endothelium at single-cell resolution. | Front Oncol | 2022 | 36185212 | PubTator, text mining | PubMed |
| Long-term osteogenic differentiation of human bone marrow stromal cells in simulated microgravity: novel proteins sighted. | Cell Mol Life Sci | 2022 | 36181557 | PubTator, text mining | PubMed |
| TLS/FUS-ERG fusion gene in acute leukemia and myelodysplastic syndrome evolved to acute leukemia: report of six cases and a literature review. | Ann Hematol | 2022 | 36181538 | PubTator, text mining | PubMed |
| Modulating cholesterol-rich lipid rafts to disrupt influenza A virus infection. | Front Immunol | 2022 | 36177026 | PubTator, text mining | PubMed |
| An adherent-invasive Escherichia coli-colonized mouse model to evaluate microbiota-targeting strategies in Crohn's disease. | Dis Model Mech | 2022 | 36172858 | PubTator, text mining | PubMed |
| The viral and inflammation hypothesis of epileptic seizures based on bioinformatic study of circulating miRNAs and peripheral whole-blood mRNAs of adult epilepsy patients. | Front Neurol | 2022 | 36172025 | PubTator, text mining | PubMed |
| Flow Cytometric Identification of Hematopoietic and Leukemic Blast Cells for Tailored Clinical Follow-Up of Acute Myeloid Leukemia. | Int J Mol Sci | 2022 | 36142442 | PubTator, text mining | PubMed |
| The updated role of exosomal proteins in the diagnosis, prognosis, and treatment of cancer. | Exp Mol Med | 2022 | 36138197 | PubTator, text mining | PubMed |
| Pan-cancer gene expression analysis of tissue microarray using EdgeSeq oncology biomarker panel and a cross-comparison with HER2 and HER3 immunohistochemical analysis. | PLoS One | 2022 | 36137139 | PubTator, text mining | PubMed |
| Electrolyte Engineering for High-Voltage Lithium Metal Batteries. | Research (Wash D C) | 2022 | 36128181 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4680/papers?page=20